Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories

Victoria M Raymond1, Stacy W Gray1, Sameek Roychowdhury1

  • 1Departments of Internal Medicine (VMR) and Pathology (AMC), University of Michigan, Ann Arbor, MI; Dana-Farber Cancer Institute, Boston, MA (SWG); Harvard Medical School, Boston, MA (SWG); The Ohio State University, Columbus, OH (SR); University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (SJ); Texas Children's Cancer Center, Houston, TX (DWP, SEP); Baylor College of Medicine, Houston, TX (DWP, SEP).